Product Name | MF | CAS | Details |
---|
ST072042 | C13H12ClNO3 | 88349-90-0 | Details |
A2764 dihydrochloride - TRESK inhibitor A2764 | C15H20Cl2N2O | 861038-72-4 | Details |
Raphin1 | C8H8Cl2N4 | 2022961-17-5 | Details |
(1-Phenyl-ethyl)-(2-piperazin-1-yl-quinazolin-4-yl)-amine | C20H23N5 | 662164-09-2 | Details |
TP0463518 | C20H18ClN3O6 | 1558021-37-6 | Details |
GeA-69 | C20H16N2O | 2143475-98-1 | Details |
2-Propenoic acid, 2-cyano-3-(3,4-dihydroxyphenyl)-, (2E)- (9CI) | C10H7NO4 | 122520-79-0 | Details |
RPW-24 | C15H13ClN4 | 1001625-82-6 | Details |
TLX agonist 1 | C23H26N4O | 958323-31-4 | Details |
TYRPHOSTIN RG 13022 | C16H14N2O2 | 136831-48-6 | Details |
2-(prop-2-en-1-yl)-6-{[(1-propyl-1H-benzimidazol-2-yl)amino]methyl}phenol | C20H23N3O | 692269-09-3 | Details |
GW 284543 hydrochloride - UNC 10225170 hydrochloride | C23H21ClN2O3 | 179246-08-3 | Details |
2-[[4-(2-Pyridinyl)-1-piperazinyl]Methyl]-1H-benziMidazole trihydrochloride | C17H22Cl3N5 | 587870-77-7 | Details |
Qstatin | C7H5BrN2O2S2 | 902688-24-8 | Details |
DG172 (dihydrochloride) | C20H21BrClN3 | 1361504-77-9 | Details |
NO-1886 | C19H20BrN2O4P | 133208-93-2 | Details |
SIS17 | C21H38N2OS | 2374313-54-7 | Details |
VU0810464 | C18H21ClFN3O | 2126040-21-7 | Details |
MMP-9-IN-1 | C16H17F2N3O3S | 502887-71-0 | Details |
VU0134992(hydrochloride) | C20H32BrClN2O2 | 1052515-91-9 | Details |
APX-115 freebase | C17H17N3O | 1270084-92-8 | Details |
(Z)-N-(4-(diethylamino)-2-hydroxybenzylidene)isonicotinohydrazide | C17H20N4O2 | 140405-36-3 | Details |
IQ 3 | C20H11N3O3 | 312538-03-7 | Details |
BTP2 | C15H9F6N5OS | 223499-30-7 | Details |
DIETHYL DITHIOBIS(THIONOFORMATE) | C6H10O2S4 | 502-55-6 | Details |
4-[(E)-2-(4-methoxyphenyl)diazenyl]-1H-pyrazole-3,5-diamine | C10H12N6O | 6975-75-3 | Details |
EUQUININE | C23H28N2O4 | 83-75-0 | Details |
PLpro inhibitor | C22H22N2O2 | 1093070-14-4 | Details |
TBOPP | C24H21F3N2O4S | 1996629-79-8 | Details |
M-3M3FBS | C16H16F3NO2S | 200933-14-8 | Details |
N-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,5-dimethoxybenzamide trifluoroacetate | C18H23F3N2O5 | 1336913-03-1 | Details |
(3-Chloro-4-methylphenyl)[4-(4-nitrophenyl)-1-piperazinyl]-methanone | C18H18ClN3O3 | 431996-53-1 | Details |
2-(2-Benzothiazolyl)-4,5,6,7-tetrahydro-2H-indazol-3-ol | C14H13N3OS | 892686-59-8 | Details |
4-Chloro-α-(1-methylethyl)-N-2-thiazolyl-benzeneacetamide | C14H15ClN2OS | 300851-67-6 | Details |
XP-59 | C15H14N4O2 | 890402-73-0 | Details |
VU-29 | C22H16N4O3 | 890764-36-0 | Details |
LCH-7749944 | C20H22N4O2 | 796888-12-5 | Details |
6-[(1-NaphthalenylMethyl)thio]-9H-purine | C16H12N4S | 313984-77-9 | Details |
iKIX1 | C10H8Cl2N4OS | 656222-54-7 | Details |
NS1652 | C15H11F3N2O3 | 1566-81-0 | Details |
SC-99 | C15H8Cl2FN3O | 882290-02-0 | Details |
N-(2-hydroxy-5-methylphenyl)-3-phenylpropanamide | C16H17NO2 | 393121-74-9 | Details |
1-(3,6-dibromocarbazol-9-yl)-3-(3-methoxyanilino)propan-2-ol | C22H20Br2N2O2 | 313268-18-7 | Details |
BAY-474 | C17H15N5 | 1033767-86-0 | Details |
COH-SR4 (Mitochondria uncoupler SR4) | C13H8Cl4N2O | 73439-19-7 | Details |
IRAK4-IN-4 | C22H16N2O2 | 1850276-58-2 | Details |
N-pyridin-3-ylthiophene-2-carboxamide | C10H8N2OS | 62289-81-0 | Details |
Benzamide, 4-ethoxy-N-(5-nitro-2-thiazolyl) | C12H11N3O4S | 312608-54-1 | Details |
tert-Butyl 3,5-bis(2-fluorobenzylidene)-4-oxopiperidine-1-carboxylate | C22H19F2NO3 | 939681-36-4 | Details |
N-(2-(1H-indol-3-yl)ethyl)-9-isopropyl-2-(5-Methylpyridin-3-yl)-9H-purin-6-aMine | C24H25N7 | 1227634-69-6 | Details |
3-fluoro-N'-[(E)-(5-nitrothiophen-2-yl)methylidene]benzohydrazide | C12H8FN3O3S | 394694-98-5 | Details |
1-[4-(2-methoxyphenyl)piperazin-1-yl]-2-phenylethanone | C19H22N2O2 | 349093-44-3 | Details |
Benzene,1,3,5-trimethyl-2-[(4-methylphenyl)sulfonyl]- | C16H18O2S | 5184-64-5 | Details |
4,6-Pyrimidinediamine, N4-cyclohexyl-N6-(4-methoxyphenyl)- | C17H22N4O | 1313491-22-3 | Details |
N-(1,3-benzothiazol-2-yl)-3,3-diphenylpropanamide | C22H18N2OS | 313480-47-6 | Details |
2-hydroxy-N'-[(E)-(2-hydroxynaphthalen-1-yl)methylidene]benzohydrazide | C18H14N2O3 | 1099592-35-4 | Details |
MS7972 | C14H13NO2 | 352553-42-5 | Details |
ALLO-2 (Smo inhibitor ALLO-2) | C18H12F3N5O | 1357350-60-7 | Details |
MB-11 | C17H12BrN3O4S | 413606-16-3 | Details |
4(3H)-Quinazolinone, 2-[(1E)-2-(3,4-dihydroxyphenyl)ethenyl]-3-(2-methoxyphenyl)- | C23H18N2O4 | 2041072-41-5 | Details |
CID-25014542 | C15H8Br2ClNO2 | 220904-99-4 | Details |
NITD-349 | C17H20F2N2O | 1473450-62-2 | Details |
3-Isoxazolecarboxamide, N-(2,4-dichlorophenyl)-5-methyl- | C11H8Cl2N2O2 | 646530-37-2 | Details |
1-HEXADECANOYL-2-(P-NITROPHENOXYSUCCINOYL)-SN-GLYCERYL-3-PHOSPHORYLCHOLINE | C16H12F3N3O2S | 170569-87-6 | Details |
DC_05 | C25H25N3O | 890643-16-0 | Details |
4(3H)-Quinazolinone, 6-fluoro-2-[(1E)-2-(5-nitro-2-furanyl)ethenyl]-3-phenyl- | C20H12FN3O4 | 2374285-52-4 | Details |
2-{[(5-methyl-2-thienyl)methylene]amino}-N-phenylbenzamide | C19H16N2OS | 1201652-50-7 | Details |
Bractoppin | C25H23FN4O | 2290527-07-8 | Details |
Urea, N-(4-chloro-3-nitrophenyl)-N'-(4-fluorophenyl)- | C13H9ClFN3O3 | 897326-30-6 | Details |
exo-IWR 1 | C25H19N3O3 | 1127442-87-8 | Details |
Mcl1-IN-2 | C19H15N3OS | 292057-76-2 | Details |
7-methylsulfanyl-3-nitro-6H-[1,2,4]triazolo[5,1-c][1,2,4]triazin-4-one | C5H4N6O3S | 123606-06-4 | Details |
IT603) | C11H9BrN2O3S | 292168-90-2 | Details |
1H-Benz[de]isoquinoline-1,3(2H)-dione, 2,2'-(iminodi-2,1-ethanediyl)bis- | C28H21N3O4 | 281224-40-6 | Details |
MLS-573151 | C21H19N3O2S | 10179-57-4 | Details |
2-Propanol, 1-[bis(phenylmethyl)amino]-3-[4-(trifluoromethyl)phenoxy]- | C24H24F3NO2 | 2222094-18-8 | Details |
KUC103479N-02 | C22H20BrN3O3S | 1222513-26-9 | Details |
[(1,1-DIOXIDOTETRAHYDROTHIEN-3-YL)AMINO]ACETIC ACID | C6H11NO4S | 51070-56-5 | Details |
2-(4-Chlorophenyl)-5-nitrobenziMidazole, 95% | C13H8ClN3O2 | 1571-87-5 | Details |
3-{[4-(pyridin-2-yl)-1,3-thiazol-2-yl]amino}phenol | C14H11N3OS | 315702-75-1 | Details |
1H-Benzimidazole, 2-(2-pyridinyl)-6-(trifluoromethoxy)- | C13H8F3N3O | 1256094-31-1 | Details |
MEISi-2 | C19H21ClN6OS | 2375595-72-3 | Details |
ML167 | C19H17N3O3 | 1285702-20-6 | Details |
N-cycloheptyl-2-(4,5-dihydro-1H-imidazol-2-ylsulfanyl)acetamide hydrochloride | C12H22ClN3OS | 1803605-68-6 | Details |
2-PyriMidinaMine, 4-(4-fluoro-1-naphthalenyl)-6-(1-Methylethyl)-, Maleate | C21H20FN3O4 | 199864-88-5 | Details |
1H-Indole-6-sulfonamide, 5-bromo-N-[4-chloro-3-(trifluoromethyl)phenyl]-1-(cyclopropylcarbonyl)-2,3-dihydro- | C19H15BrClF3N2O3S | 1207660-00-1 | Details |
Benzoic acid, 4-hydroxy-, 2-[(Z)-(2-oxo-1(2H)-naphthalenylidene)methyl]hydrazide | C18H14N2O3 | 2250156-71-7 | Details |
1,6-Heptadiene-3,5-dione, 1,7-bis(3,4-dimethoxyphenyl)-4-[(4-hydroxy-3-methoxyphenyl)methylene]-, (1E,6E)- | C31H30O8 | 1227098-15-8 | Details |
Sephin 1 | C8H9ClN4 | 951441-04-6 | Details |
4(3H)-Pyrimidinone, 6-methyl-2-[[2-(1-naphthalenyl)-2-oxoethyl]thio]- | C17H14N2O2S | 459420-09-8 | Details |
Acetamide, N-[4-(6-chloro-2-quinoxalinyl)phenyl]- | C16H12ClN3O | 2412270-22-3 | Details |
HOIPIN-1 | C17H14O4.Na | 2470242-33-0 | Details |
Thalidomide-NH-C4-NH-Boc | C22H28N4O6 | 2093388-52-2 | Details |
2-{[(5-bromo-2-thienyl)methylene]amino}benzamide | C12H9BrN2OS | 304456-62-0 | Details |
2-Naphthalenecarboxamide, N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]- | C26H31N3O2 | 192384-87-5 | Details |
Benzo[b]thiophene-2-carboxamide, N-[4-[4-(2-methoxyphenyl)-1-piperazinyl]butyl]- | C24H29N3O2S | 474432-65-0 | Details |
Mito-TEMPO | C29H35N2O2P.Cl | 1334850-99-5 | Details |
2,4-Thiazolidinedione,5-(1,3-benzodioxol-5-ylmethylene)- | C11H7NO4S | 6318-41-8 | Details |
MAT2Ainhibitor1 | C18H24ClN3O3 | 13299-99-5 | Details |
Luzindole. | C19H20N2O | 117946-91-5 | Details |
Product Total: Product Page: | ||||
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 |